Determining the optimal timing of fruit harvest in transgenic tomato expressing F1-V, a candidate subunit vaccine against plague

Ryo Matsuda, Chieri Kubota, M. Lucrecia Alvarez, Guy A. Cardineau

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

Changes in the amounts of F1-V, an antigen fusion protein and a candidate subunit vaccine against plague, and total soluble protein (TSP) in green fruit of transgenic tomato plants were investigated to identify the optimum harvest timing to maximize the F1-V yields. Two T2 progenies of the transgenic plant, '22.11.21' and '22.11.5', were grown. The F1-V concentration rapidly decreased at the beginning of the green stage and decreased to less than 5% of the initial concentration at the late green stage in '22.11.21'. The F1-V concentration also decreased as fruit size increased in '22.11.5', but the pattern of the decrease was linear and different from that in '22.11.21'. The concentration of TSP also decreased with fruit growing in both plants. When calculated on a whole fruit basis, the F1-V content linearly decreased with increasing fruit size in '22.11.21'. In '22.11.5', the F1-V content per fruit also tended to decrease from the middle to late green stage. Based on these observations, collecting small green fruits without pruning was proposed as a harvest practice that may maximize the F1-V yields. Thus, the optimum protocols for harvesting and pruning for plant-made pharmaceutical production may be substantially different from those currently used in commercial hydroponic greenhouses for fresh market tomato.

Original languageEnglish (US)
Pages (from-to)347-351
Number of pages5
JournalHortScience
Volume45
Issue number3
StatePublished - Mar 2010

Fingerprint

plague
subunit vaccines
genetically modified organisms
tomatoes
fruits
pruning
fresh market
proteins
fruit growing
hydroponics
transgenic plants
antigens
greenhouses
drugs

Keywords

  • Controlled environment agriculture
  • High-value protein
  • Molecular farming
  • Plant-made pharmaceuticals (PMP)
  • Solanum lycopersicum
  • Subunit vaccine

ASJC Scopus subject areas

  • Horticulture

Cite this

Determining the optimal timing of fruit harvest in transgenic tomato expressing F1-V, a candidate subunit vaccine against plague. / Matsuda, Ryo; Kubota, Chieri; Lucrecia Alvarez, M.; Cardineau, Guy A.

In: HortScience, Vol. 45, No. 3, 03.2010, p. 347-351.

Research output: Contribution to journalArticle

@article{9b4ee5e812ed446191d32a29d948e579,
title = "Determining the optimal timing of fruit harvest in transgenic tomato expressing F1-V, a candidate subunit vaccine against plague",
abstract = "Changes in the amounts of F1-V, an antigen fusion protein and a candidate subunit vaccine against plague, and total soluble protein (TSP) in green fruit of transgenic tomato plants were investigated to identify the optimum harvest timing to maximize the F1-V yields. Two T2 progenies of the transgenic plant, '22.11.21' and '22.11.5', were grown. The F1-V concentration rapidly decreased at the beginning of the green stage and decreased to less than 5{\%} of the initial concentration at the late green stage in '22.11.21'. The F1-V concentration also decreased as fruit size increased in '22.11.5', but the pattern of the decrease was linear and different from that in '22.11.21'. The concentration of TSP also decreased with fruit growing in both plants. When calculated on a whole fruit basis, the F1-V content linearly decreased with increasing fruit size in '22.11.21'. In '22.11.5', the F1-V content per fruit also tended to decrease from the middle to late green stage. Based on these observations, collecting small green fruits without pruning was proposed as a harvest practice that may maximize the F1-V yields. Thus, the optimum protocols for harvesting and pruning for plant-made pharmaceutical production may be substantially different from those currently used in commercial hydroponic greenhouses for fresh market tomato.",
keywords = "Controlled environment agriculture, High-value protein, Molecular farming, Plant-made pharmaceuticals (PMP), Solanum lycopersicum, Subunit vaccine",
author = "Ryo Matsuda and Chieri Kubota and {Lucrecia Alvarez}, M. and Cardineau, {Guy A.}",
year = "2010",
month = "3",
language = "English (US)",
volume = "45",
pages = "347--351",
journal = "Hortscience: A Publication of the American Society for Hortcultural Science",
issn = "0018-5345",
publisher = "American Society for Horticultural Science",
number = "3",

}

TY - JOUR

T1 - Determining the optimal timing of fruit harvest in transgenic tomato expressing F1-V, a candidate subunit vaccine against plague

AU - Matsuda, Ryo

AU - Kubota, Chieri

AU - Lucrecia Alvarez, M.

AU - Cardineau, Guy A.

PY - 2010/3

Y1 - 2010/3

N2 - Changes in the amounts of F1-V, an antigen fusion protein and a candidate subunit vaccine against plague, and total soluble protein (TSP) in green fruit of transgenic tomato plants were investigated to identify the optimum harvest timing to maximize the F1-V yields. Two T2 progenies of the transgenic plant, '22.11.21' and '22.11.5', were grown. The F1-V concentration rapidly decreased at the beginning of the green stage and decreased to less than 5% of the initial concentration at the late green stage in '22.11.21'. The F1-V concentration also decreased as fruit size increased in '22.11.5', but the pattern of the decrease was linear and different from that in '22.11.21'. The concentration of TSP also decreased with fruit growing in both plants. When calculated on a whole fruit basis, the F1-V content linearly decreased with increasing fruit size in '22.11.21'. In '22.11.5', the F1-V content per fruit also tended to decrease from the middle to late green stage. Based on these observations, collecting small green fruits without pruning was proposed as a harvest practice that may maximize the F1-V yields. Thus, the optimum protocols for harvesting and pruning for plant-made pharmaceutical production may be substantially different from those currently used in commercial hydroponic greenhouses for fresh market tomato.

AB - Changes in the amounts of F1-V, an antigen fusion protein and a candidate subunit vaccine against plague, and total soluble protein (TSP) in green fruit of transgenic tomato plants were investigated to identify the optimum harvest timing to maximize the F1-V yields. Two T2 progenies of the transgenic plant, '22.11.21' and '22.11.5', were grown. The F1-V concentration rapidly decreased at the beginning of the green stage and decreased to less than 5% of the initial concentration at the late green stage in '22.11.21'. The F1-V concentration also decreased as fruit size increased in '22.11.5', but the pattern of the decrease was linear and different from that in '22.11.21'. The concentration of TSP also decreased with fruit growing in both plants. When calculated on a whole fruit basis, the F1-V content linearly decreased with increasing fruit size in '22.11.21'. In '22.11.5', the F1-V content per fruit also tended to decrease from the middle to late green stage. Based on these observations, collecting small green fruits without pruning was proposed as a harvest practice that may maximize the F1-V yields. Thus, the optimum protocols for harvesting and pruning for plant-made pharmaceutical production may be substantially different from those currently used in commercial hydroponic greenhouses for fresh market tomato.

KW - Controlled environment agriculture

KW - High-value protein

KW - Molecular farming

KW - Plant-made pharmaceuticals (PMP)

KW - Solanum lycopersicum

KW - Subunit vaccine

UR - http://www.scopus.com/inward/record.url?scp=77950452363&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77950452363&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:77950452363

VL - 45

SP - 347

EP - 351

JO - Hortscience: A Publication of the American Society for Hortcultural Science

JF - Hortscience: A Publication of the American Society for Hortcultural Science

SN - 0018-5345

IS - 3

ER -